Personalized Cell Therapy Market: How Is the Cost-Effectiveness Challenge Shaping Market Access?
Cost-effectiveness challenge shaping cell therapy market access — the fundamental tension between personalized cell therapy's extraordinary per-treatment costs ($350,000-500,000 for CAR-T) and health system reimbursement frameworks designed for chronic treatment cost models rather than high-cost one-time curative interventions — creating healthcare financing innovation imperatives...
0 Kommentare 0 Geteilt 411 Ansichten 0 Bewertungen